Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/19/07 → 9/30/11 |
Funding
- Fresenius Biotech North America: $15,763.00
Protocol EZ-2053-001: A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-T Lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary
- Mullett, Timothy (PI)